Agfa-Gevaert NV (EBR:AGFB)
Belgium · Delayed Price · Currency is EUR | Market Cap | 73.62M -46.6% |
| Revenue (ttm) | 1.11B -1.9% |
| Net Income | -72.00M |
| EPS | -0.41 |
| Shares Out | 154.82M |
| PE Ratio | n/a |
| Forward PE | 14.25 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 35,665 |
| Average Volume | 106,548 |
| Open | 0.4900 |
| Previous Close | 0.4800 |
| Day's Range | 0.4755 - 0.4900 |
| 52-Week Range | 0.4185 - 1.1800 |
| Beta | 0.58 |
| RSI | 49.21 |
| Earnings Date | Mar 11, 2026 |
About Agfa-Gevaert NV
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems worldwide. It operates through four segments: HealthCare IT, Digital Print and Chemicals, Radiology Solutions, and Contractor Operations and Services (CONOPS). The Healthcare IT segment provides healthcare’s enterprise imaging platform. The Digital Print & Chemicals segment offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billb... [Read more]
Financial Performance
In 2024, Agfa-Gevaert NV's revenue was 1.14 billion, a decrease of -1.04% compared to the previous year's 1.15 billion. Losses were -92.00 million, -9.80% less than in 2023.
Financial StatementsNews
Q4 2025 AGFA Gevaert NV Earnings Call Transcript
Q4 2025 AGFA Gevaert NV Earnings Call Transcript
Agfa-Gevaert Group in 2025: strong Q4 profitability and free cash flow – good step-up in FY profitability in HealthCare IT and Digital Print & Chemicals
Regulated information March 11, 2026 - 7:45 a.m. CET Agfa-Gevaert Group in 2025: strong Q4 profitability and free cash flow – good step-up in FY profitability in HealthCare IT and Digital Pri...
Agfa-Gevaert NV signs new revolving credit facility - Regulated information - Contains inside information
August 1, 2025 – 6.00 PM CET Regulated information - Contains inside information Agfa-Gevaert NV signs new revolving credit facility Mortsel, Belgium – August 1, 2025 – 6.00 p.m. CET Agfa-Gevaert NV h...
Arbitral Tribunal acting under ICC Rules of Arbitration issues final award in an arbitration between Agfa-Gevaert and the insolvency receiver of AgfaPhoto GmbH
June 27, 2025 - 1.45 PM CET Regulated information – Contains inside information Arbitral Tribunal acting under ICC Rules of Arbitration issues final award in an arbitration between Agfa-Gevaert and th...
The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline
Regulated information May 14, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market de...
Annual General Meeting of Agfa-Gevaert NV - regulated information
May 13, 2025 – 5.40 PM CET Regulated information Annual General Meeting of Agfa-Gevaert NV Mortsel, Belgium – May 13, 2025 – 5.40 p.m. CET At Agfa-Gevaert's Annual General Meeting, the 2024 financial ...
The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets - regulated information
Regulated information March 12, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in 2024: strong performance from growth engines offsets decline in traditional film markets The Agfa-Gevaert Group ...
Extraordinary General Meeting of Agfa-Gevaert NV - regulated information
March 11, 2025 – 5.40 PM CET Regulated information Extraordinary General Meeting of Agfa-Gevaert NV Mortsel, Belgium – March 11, 2025 – 5.40 p.m. CET On Tuesday, March 11, Agfa held an Extraordinary G...
Special General Meeting of Agfa-Gevaert NV
February 28, 2025 – 5.40 PM CET Regulated information Special General Meeting of Agfa-Gevaert NV Mortsel, Belgium – February 28, 2025 – 5.40 p.m. CET On Friday, February 28, Agfa held a Special Genera...
The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro - regulated information
Regulated information November 14, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro
Fiona Lam appointed as CFO for the Agfa-Gevaert Group - Regulated information - Contains inside information
October 14, 2024 - 7:45 a.m. CET Regulated information - Contains inside information Fiona Lam appointed as CFO for the Agfa-Gevaert Group Mortsel, Belgium – October 14, 2024 – 7:45 a.m.
The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines - regulated information - inside information
Regulated information – Inside information August 28, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2024: solid quarter, powered by growth engines
The Agfa-Gevaert Group in Q1 2024: weak start of the year, full year outlook maintained - regulated information
Regulated information – May 14, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2024: weak start of the year, full year outlook maintained HealthCare IT: Soft quarter following a strong Q4 ...
Correction: The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information
CORRECTION ONLY IN DUTCH VERSION Regulated information – March 13, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, po...
The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information
Regulated information – March 13, 2024 - 7:45 a.m. CET The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines HealthCare IT: Strong improvement in profit...
The Agfa-Gevaert Group in Q3 2023: overall EBITDA growth driven by strong performance of the growth engines, while film business under pressure
Regulated information – November 15, 2023 - 7:45 a.m. CET The Agfa-Gevaert Group in Q3 2023: overall EBITDA growth driven by strong performance of the growth engines, while film business unde...
Agfa-Gevaert: Publication of a transparency notification – Regulated information
Publication of a transparency notification – Regulated information (Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings) Mortsel, Belgium – November 8, 2023 – 7.45 a.m....
The Agfa-Gevaert Group in Q2 2023: continued progress for the growth engines
Regulated information – August 23 , 20 2 3 - 7:45 a.m. CET The Agfa-Gevaert Group in Q 2 202 3 : continued progress for the growth engines HealthCare IT: Increase in order intake of 1...
The Agfa-Gevaert Group in Q1 2023 - regulated information
Regulated information – May 9 , 20 2 3 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 202 3 : HealthCare IT: Increase in order intake of 25%, 4.8% revenue increase Profitability impacte...
Agfa-Gevaert Group Q3 Results 2022 - Regulated information – November 9, 2022 - 7:45 a.m. CET
Adjusted EBITDA increase of 8% with contrasted performances between the divisions HealthCare IT: organic sales growth, strong increase in order intake, solid profitability Digital Print & Chemicals: c...
Agfa-gevaert : Publication of a transparency notification – Regulated information
(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)
Agfa-Gevaert Group and AURELIUS Group sign share purchase agreement for sale of Agfa's Offset Solutions division - Regulated information
Mortsel, Belgium – August 30, 2022 – 8.15 a.m. CET
Agfa-Gevaert Half Year 2022 Results - Regulated information
Top line growth driven by Digital Print & Chemicals and Offset Solutions. Order book HealthCare IT at very healthy level – strong growth in order intake
Agfa-Gevaert: Cancellation of treasury shares – regulated information
Mortsel, Belgium – July 5, 2022 – 5:40 p.m. CET
Agfa-Gevaert : Share buyback program 2021 completed – regulated information
Mortsel, Belgium – June 13, 2022 – 5:40 p.m. CET